Transforming growth factor-beta (TGF-β), mainly secreted by immunosuppressive cells and tumor cells, limits CAR-T cell efficacy in solid tumors by suppressing T cell activation, proliferation, migration, and differentiation [44–46]. This evidence concerns the gene TGFB1 and neoplasm.